|
PRKD1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.7788996638285E-10 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.12940001795181E-09 |
| Normal-vs-Stage2 |
1.43929999996129E-06 |
| Normal-vs-Stage3 |
1.76050000022521E-07 |
| Normal-vs-Stage4 |
1.4826999999995E-06 |
| Stage1-vs-Stage2 |
8.850200E-01 |
| Stage1-vs-Stage3 |
7.571000E-01 |
| Stage1-vs-Stage4 |
2.522200E-01 |
| Stage2-vs-Stage3 |
9.047800E-01 |
| Stage2-vs-Stage4 |
2.627400E-01 |
| Stage3-vs-Stage4 |
3.165600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.95510000411403E-08 |
| Normal-vs-AfricanAmerican |
1.23370202942397E-11 |
| Normal-vs-Asian |
1.034380E-04 |
| Caucasian-vs-AfricanAmerican |
2.557800E-01 |
| Caucasian-vs-Asian |
2.846000E-01 |
| AfricanAmerican-vs-Asian |
2.580000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.01736413632625E-12 |
| Normal-vs-Female |
2.19750000000074E-05 |
| Male-vs-Female |
6.497700E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.85840000055393E-08 |
| Normal-vs-Extreme_Weight |
1.88860038718985E-10 |
| Normal-vs-Obese |
1.5876999999942E-05 |
| Normal-vs-Extreme_Obese |
2.77159999995114E-06 |
| Normal_Weight-vs-Extreme_Weight |
9.654400E-01 |
| Normal_Weight-vs-Obese |
1.764400E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.058400E-01 |
| Extreme_Weight-vs-Obese |
1.174420E-01 |
| Extreme_Weight-vs-Extreme_Obese |
3.592800E-01 |
| Obese-vs-Extreme_Obese |
1.521240E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.60260000000268E-05 |
| Normal-vs-Age(41-60Yrs) |
4.61500000004111E-06 |
| Normal-vs-Age(61-80Yrs) |
1.26954002865887E-12 |
| Normal-vs-Age(81-100Yrs) |
6.20339999999331E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.656600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.871600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.000400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.540000E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.252000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.454000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.59700000001983E-07 |
| Normal-VS-Type2 PRCC |
4.11819467416308E-11 |
| Normal-VS-KIRP CIMP |
8.18170000000951E-05 |
| Normal-VS-Unclassified PRCC |
1.56031999999362E-05 |
| Type1 PRCC-VS-Type2 PRCC |
4.225800E-02 |
| Type1 PRCC-VS-KIRP CIMP |
3.787600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
6.243600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
9.850400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
3.191200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
5.850200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.09550163279937E-11 |
| Normal-vs-N1 |
9.84970000006413E-08 |
| Normal-vs-N2 |
1.395420E-04 |
| N0-vs-N1 |
6.576200E-01 |
| N0-vs-N2 |
1.830370E-01 |
| N1-vs-N2 |
1.073210E-01 |
|
|
